SCHEMBL17376106

SCHEMBL17376106

CC(=O)OCCN(C)c1cc(C(N)=O)c(N)cn1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.33
▸ MCHR1 Q99705 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ AURKA O14965 2/20 0.33
▸ RPS6KB1 P23443 2/20 0.33
▸ HCAR3 P49019 1/20 0.32
▸ DGAT1 O75907 3/20 0.32
▸ NNMT P40261 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ AURKB Q96GD4 1/20 0.31
▸ PHLPP2 Q6ZVD8 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ GPBAR1 Q8TDU6 1/20 0.31
▸ RAD52 P43351 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19268055 0.82 HCAR3 (0.48) ALDH1A1MEN1LMNAMAPTKMT2A
SCHEMBL17376260 0.82 ALDH1A1 (0.40) HTTMCHR1ALDH1A1MEN1LMNA
SCHEMBL17384196 0.76 FASN (0.33) MCHR1AURKARPS6KB1DGAT1
Hydrochloric Acid SCHEMBL4365233 0.69 NNMT (0.32) MEN1KMT2ANNMTHSD17B10
SCHEMBL29980916 0.67 ADK (0.40) DGAT1GPBAR1
SCHEMBL13455116 0.67 ADK (0.40) DGAT1GPBAR1
SCHEMBL23903736 0.67 PIK3CA (0.36) ALDH1A1MEN1GAAMAPTKMT2A
SCHEMBL31140636 0.65 NNMT (0.49) MCHR1HCAR3NNMT
SCHEMBL25239937 0.65 NNMT (0.49) MCHR1HCAR3NNMT
SCHEMBL17376093 0.64 ALDH1A1 (0.49) HTTALDH1A1LMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261164-B2 Small molecule agonists of neurotensin receptor 1 Sanford Burnham Prebys Medical Discovery Institute (US) 2022-03-01 — — US disclosed
US-20200354324-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 2020-11-12 — — US disclosed
US-20200354324-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 2020-11-12 — — US disclosed
US-10584103-B2 Small molecule agonists of neurotensin receptor 1 Sanford Burnham Prebys Medical Discovery Institute (US) 2020-03-10 — — US disclosed
US-20190023665-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 Sanford Burnham Prebys Medical Discovery Institute 2019-01-24 — — US disclosed
US-20190023665-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 Sanford Burnham Prebys Medical Discovery Institute 2019-01-24 — — US disclosed
US-10118902-B2 Small molecule agonists of neurotensin receptor 1 Sanford Burnham Prebys Medical Discovery Institute (US) 2018-11-06 — — US disclosed
US-20170240514-A1 Small Molecule Agonists of Neurotensin Receptor 1 Sanford Burnham Prebys Medical Discovery Institute 2017-08-24 — — US disclosed
US-20170240514-A1 Small Molecule Agonists of Neurotensin Receptor 1 Sanford Burnham Prebys Medical Discovery Institute 2017-08-24 — — US disclosed
EP-3160961-A2 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 Sanford-Burnham Medical Research Institute (US) 2017-05-03 — — EP disclosed
WO-2015200534-A2 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2015-12-30 — — WO disclosed
WO-2015200534-A2 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2015-12-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10584103-B2 Small molecule agonists of neurotensin receptor 1 NTSR1, NTSR2, VIPR1 HTT 893/4885MCHR1 27/4885ALDH1A1 3294/4885
US-11261164-B2 Small molecule agonists of neurotensin receptor 1 NTSR1, NTSR2, VIPR1 HTT 893/4885MCHR1 27/4885ALDH1A1 3294/4885
US-20170240514-A1 Small Molecule Agonists of Neurotensin Receptor 1 NTSR1, NTSR2, VIPR1 HTT 893/4885MCHR1 27/4885ALDH1A1 3294/4885
US-10118902-B2 Small molecule agonists of neurotensin receptor 1 NTSR1, NTSR2, VIPR1 HTT 893/4885MCHR1 27/4885ALDH1A1 3294/4885
US-20200354324-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 NTSR1, NTSR2, VIPR1 HTT 893/4885MCHR1 27/4885ALDH1A1 3294/4885
US-20190023665-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 NTSR1, NTSR2, VIPR1 HTT 893/4885MCHR1 27/4885ALDH1A1 3294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback